This article first appeared on GuruFocus.
Cathie Wood’s ARK Invest made additional portfolio adjustments, continuing moves seen in prior sessions.
The firm increased holdings in WeRide Inc. (NASDAQ:WRD), a self-driving technology developer. ARK purchased 101,637 shares through its ARK Autonomous Technology & Robotics ETF (ARKQ) for roughly $902,000.This follows earlier purchases on Dec. 22 and Dec. 23, signaling continued confidence in the company’s growth prospects.
ARK also added to positions in CRISPR Therapeutics (NASDAQ:CRSP). The fund bought 10,353 shares through the ARK Innovation ETF (ARKK) and ARK Genomic Revolution ETF (ARKG), valued at around $585,000. Earlier buys in the stock were recorded on Dec. 22 and Dec. 23, highlighting sustained interest in the gene-editing sector.
On the selling side, ARK trimmed its stake in Ibotta Inc. (NYSE:IBTA), disposing of 101 shares through the ARK Next Generation Internet ETF (ARKW) for about $2,200. This follows small reductions in recent sessions, reflecting a measured approach to portfolio rebalancing.